Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
160 participants
INTERVENTIONAL
2015-03-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With ADHD
NCT00712699
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
NCT00301236
Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)
NCT01740206
Stimulant Effects on Brain Activity
NCT02453698
Safety of SPD465 in Treating Adults With ADHD.
NCT00152035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CDP-choline+supportive psychotherapy
CDP-choline 500mg once a day for 12 weeks / Supportive psychotherapy 1 session/2 weeks for 12 weeks
CDP-choline
CDP-choline 500mg once a day for 12 weeks
Supportive psychotherapy
Supportive psychotherapy 1 session/2 weeks for 12 weeks
Placebo+supportive psychotherapy
Placebo 500mg once a day for 12 weeks / Supportive psychotherapy 1 session/2 weeks for 12 weeks
Placebo
Placebo 500mg once a day for 12 weeks
Supportive psychotherapy
Supportive psychotherapy 1 session/2 weeks for 12 weeks
Healthy control
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CDP-choline
CDP-choline 500mg once a day for 12 weeks
Placebo
Placebo 500mg once a day for 12 weeks
Supportive psychotherapy
Supportive psychotherapy 1 session/2 weeks for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Amphetamine (or amphetamine-like) use disorder (DSM-IV-TR)
* Informed consent
* Seeking treatment
Exclusion Criteria
* Psychiatric illnesses requiring hospitalization, prescription of psychotropic medications, or emergency psychiatric interventions
* Current and past diagnosis of a psychotic disorder, bipolar disorder, conduct disorder, or attention-deficit hyperactivity disorder
* Occasional ATS use (less than monthly use)
* IQ of 80 or lower
* Pregnancy or breastfeeding
* Clinically significant suicidal or homicidal ideation
* Substance use disorders (substances other than amphetamine or MA)
14 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ewha Womans University Mokdong Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sujung Yoon
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ewha Womans University Mokdong Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH_ATS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.